EDIT Q3 2023 Earnings — Editas Medicine, Inc. Revenue & Financial Results | Market Cap Arena

EDITEditas Medicine, Inc.

$256M

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$5M+12604.8% YoY

Gross Profit

$4M71.6% margin

Operating Income

-$50M-940.1% margin

Net Income

-$45M-843.7% margin

EPS (Diluted)

$-0.55

QoQ Revenue Growth

+84.8%

Cash Flow

Operating Cash Flow

-$35M

Free Cash Flow

-$36M

Stock-Based Comp.

$5M

Balance Sheet

Total Assets

$505M

Total Liabilities

$144M

Stockholders' Equity

$360M

Cash & Equivalents

$83M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$5M	$42,000	+12604.8%
Gross Profit	$4M	-$41M	+109.3%
Operating Income	-$50M	-$58M	+12.8%
Net Income	-$45M	-$56M	+19.2%